N1-{4-[(10S)-dihydroartemisinin-10-oxyl]}phenylmethylene-N2-(6-chloro-2-methylquinoline-4-yl)hydrazine

ID: ALA2235031

Chembl Id: CHEMBL2235031

PubChem CID: 76315163

Max Phase: Preclinical

Molecular Formula: C32H36ClN3O5

Molecular Weight: 578.11

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc(N/N=C/c2ccc(O[C@H]3O[C@@H]4O[C@@]5(C)CC[C@H]6[C@H](C)CC[C@@H]([C@H]3C)[C@@]46OO5)cc2)c2cc(Cl)ccc2n1

Standard InChI:  InChI=1S/C32H36ClN3O5/c1-18-5-11-26-20(3)29(38-30-32(26)25(18)13-14-31(4,39-30)40-41-32)37-23-9-6-21(7-10-23)17-34-36-28-15-19(2)35-27-12-8-22(33)16-24(27)28/h6-10,12,15-18,20,25-26,29-30H,5,11,13-14H2,1-4H3,(H,35,36)/b34-17+/t18-,20-,25+,26+,29+,30-,31-,32-/m1/s1

Standard InChI Key:  OBNCDLMUQCIGSS-YTJKISDPSA-N

Associated Targets(Human)

MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK8 Tchem c-Jun N-terminal kinase, JNK (688 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Falcipain 2 (539 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 578.11Molecular Weight (Monoisotopic): 577.2343AlogP: 7.23#Rotatable Bonds: 5
Polar Surface Area: 83.43Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 6.47CX LogP: 7.89CX LogD: 7.85
Aromatic Rings: 3Heavy Atoms: 41QED Weighted: 0.19Np Likeness Score: 1.03

References

1. Luo W, Lu W, Cui K, Liu Y, Wang J, Guo C.  (2012)  N 1-{4-[(10S)-Dihydroartemisinin-10-oxyl]}phenylmethylene-N 2-(2-methylquinoline-4-yl)hydrazine derivatives as antiplasmodial falcipain-2 inhibitors,  21  (10): [10.1007/s00044-011-9854-3]
2. Hu YQ, Gao C, Zhang S, Xu L, Xu Z, Feng LS, Wu X, Zhao F..  (2017)  Quinoline hybrids and their antiplasmodial and antimalarial activities.,  139  [PMID:28800458] [10.1016/j.ejmech.2017.07.061]
3. Gao F, Sun Z, Kong F, Xiao J..  (2020)  Artemisinin-derived hybrids and their anticancer activity.,  188  [PMID:31945642] [10.1016/j.ejmech.2020.112044]

Source